FDA Investigator Gianine E Tompkins

Gianine E Tompkins has conducted inspections on 214 sites in 7 countries as of 11 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
214
Last Inspection Date:
11 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Japan, China, France, Germany, Korea (Republic of), Thailand
FDA Investigators that have inspected at least one site in common with Gianine E Tompkins:
Alberto A Viciedo, Allen Lou, Amanda M Osteen, Amy L Singer, Amy M Cramer, Amy Wyan Mai, Ana S Cabrera, Andrew F Cohen, Andrew J Molesky, Ann Marie Karnick, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Anthony M Criscuolo, Jr, Arthur G Hurst, Audrey Thereset Uy, Barbara J Maulfair, Barbara Jwilimczyk Macri, Brandi L Garbutt, Brandon J Brookens, Byungja E Marciante, Calvin W Edwards, Cary Greene, Cassandra Gasby, Charisse K Green, Charles J Chacko, Charlotte P Chang, Christina N Maurino, Craig W Swanson, Crayton Lee, Crystal A Harlan, Cynthia Jim, CSO, Daniel J Grabicki, Daniel W Johnson, David H Smith, David R Delucia, Deborah B Nixon, Dena M Elimam, Devon Jenkins, Dhaval H Patel, Dinesh Kumar, Doreen P Gubbay, Douglas C Kovacs, Edward O'shaughnessy, Emest F Bizjak, Emilio Z Azukwu, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Eric S Myskowski, Erin D Mccaffery, Frank A Boardwick, Frank Wackes, Frans E Mercado, Frederick F Razzaghi, Gianine E Delade, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Iqra Iftikhar, Jacqueline A O'shaughnessy, PhD, James R Birkenstamm, Janet A Rajan, Jason Kwong, Jason M Sluzynski, Jawaid Hamid, Jean Blackston Hill, Jeffrey J Ebersole, Jennifer Macmillan, Jessica M Monteiro, Jill M Sooter, Jogy George, Jose M Cayuela, Jose Perez Soto, Jose V Obando, Joseph Duca, Joseph S Fanelli, Joseph T Dougherty, Joy F Canlas, Joy Rkozlowski Klena, Julianne C Mccullough, Justin C Fuller, Justina A Vicioso, Justine Tomasso, Kailee R Mason, Karen E D'orazio, Karen F Tomaziefski, Karla J Gibler, Kazi Rafiquzzaman, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kelly I Anderson, Kerry A Donovan, Kerry A Kurdilla, Kevin K Cole, Kim G Campbell, Kinh Q Mac, Kris K Moore, Krishnaiah Yellela, Kristy A Zielny, Krystal O Ogunremi, Kyle D Covill, Kyle S Hobson, L Izaam Lam, Laishan L Lam, Larry Johnson, Larry K Austin, Lata C Mathew, PhD, Lawrence Harmon, Jr, Lawrence R Johnson, Leticia S Jones, Li Li, Liatte Kreuger, PharmD, Lisa M Bellows, Lisa M Feola, Lisa Mathew, LT John M Mastalski, Luis A Dasta, Lynn L Wong, Maotang Zhou, PhD, Marcelo O Mangalindan, Jr, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Manzoni, PhD, Marie B Buen Bigornia, Marjorie D Schultz, Matthew A Spataro, Matthew B Thomaston, Maureen A Wentzel, Melba Trivera Clavell, Melissa B Libby, Melissa M Dauksis, Melissa M Schafer, Melissa T Roy, Meredith L Sheridan, Michael R Klapal, Michael Serrano, Miguel Gmanzano Maldonado, Nancy F Scheraga, Nancy M Espinal, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nilufer M Tampal, PhD, Nympha V Florendo, Paul L Bellamy, Perez, Peter R Lenahan, Phillip O Mathis, Randolph Campos Santiago, Raymond L Cheung, Regina T Brown, Remache, Richard D Manney, Richard W Thornton, Robert D Ogan, Robert D Tollefsen, Robin P Mathew, Rodrigo Vilchez, Saleem A Akhtar, Sandra Kershaw, Sara Jdent Acosta, Sarah Forney, Schultz, Shahla Parvizi, Sherri J Liu, Shreya Shah, Sidney B Priesmeyer, Sierra M Shockley, Sinai I Davis, Siobhan A Gallagher, Siobhan G Taylor, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven S Wahl, Susan M Halsted, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Teigan M Mule, Thomas J Hudson, Thomas N Adjabeng, Tiffani D Wilson, Todd J Maushart, Tonia F Bernard, Tressa T Lewis, Unnee Ranjan, Valerie C Reed, Wayne J Meyer, William J Muszynski, William V Thompson, Willy A Orantes, Yasmin B Rios, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhijin Chen

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more